Assessment of hemoglobin status among cancer patients: a hospital based study

Munish Kumar Sharma, Sanjay Choudhary, Neeraj Gour, Awadhesh Pandey, Meenakshi Chaudhary, Dhiraj Srivastava


Background: Cancer related anemia (CRA) is a major healthcare issue among patients suffering with cancer. In the Indian context, these figures are likely to be higher due to the prevailing malnutrition and low socio-economic status in the general population. This observational hospital-based study has been conducted among cancer patients with following objectives to assess the socio demographic profile of different cancer patients admitted at hospital. To measure hemoglobin level among different cancer patients admitted at hospital on the basis of socio demographic profile and type of cancer.

Methods: The registers maintained in the department of Radiotherapy were checked and those belonging to the year 2011-12 were used to process and analyse the cancer patient’s data in respect to age, type of cancer, hemoglobin level admitted in health care facility.

Results: By far distribution of Hb level is concerned among all cancer patients, 87.56% patients were having Hb level more than 9 gm% and around 12.43 % patients were having Hb level less than 9 gm%. Majority of patients whose Hb level was less than 9gm% were belonging to age group more than 45 years.

Conclusions: It is very much evident that anemia among cancer patients is a major healthcare problem and surely adds into morbidity and mortality of cancer patients. It may further aggravate the health condition of cancer patients if not corrected timely. Therefore, anemia among cancer patients should be taken and treated very seriously.


Anemia, Cancer patients, Hemoglobin, Hospital based study

Full Text:



Ludwig H, Van Belle S, Barrett-Lee P, Birgegård G, Bokemeyer C, Gascón P, et al. The European Cancer Anaemia Survey (ECAS): Alarge, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40(15):2293-306.

Parikh PM, Bakshi A. Cancer related Anemia-Guidelines for Developing Countries. Mumbai, India: Elsevier; 2004.

Bahl A, Sharma DA, Basu J, Rath GK, Julka PK. Pretreatment anemia evaluation in cancer patients attending radiotherapy clinic: Results from a single Indian center. Indian J Med Sci. 2008;62:417-20.

The National Family Health Survey (NFHS-3) of India, 2005-06. Available at: Accessed 01 December 2019.

Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J National Cancer Institute. 1999;91(19):1616-34.

Cella D. Quality of life and clinical decisions in chemotherapy-induced anemia. Oncol. 2006;20:6.

Kanuri G, Sawhney R, Varghese J, Britto M, Shet A. Iron deficiency anemia coexists with cancer related anemia and adversely impacts quality of life. PloS one. 2016;11(9):0163817.

Flávio Augusto Naoum. Iron deficiency in cancer patients. Rev Bras Hematol Hemoter. 2016;38(4):325-30.

Steegmann JL, Torres JS, Colomer R, Vaz A, Lopez J, Jalon I, et al. Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey. Clin Translat Oncol. 2013;15(6):477-83.

Merlini L, Cartenì G, Iacobelli S, Stelitano C, Airoldi M, Balcke P, et al. Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy. Cancer Management Res. 2013;5:205.

Verbeke N, Beguin Y, Wildiers H, Canon JL, Bries G, Bosly A, et al. High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008). Supportive care in cancer. 2012;20(1):23-8.

Seshadri T, Prince HM, Bell DR, Coughlin PB, James PP, Richardson GE, et al. The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer. Med J Australia. 2005;182(9):453-7.

Kitano T, Tada H, Nishimura T, Teramukai S, Kanai M, Nishimura T, et al. Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy. Intern J Hematol. 2007;86(1):37-41.

Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol. 2008;26(1):132-49.

Aapro MS, Link H. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. The Oncol. 2008;13(3):33-6.